Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Features

European Data Protection Supervisor Suggests Path After Parliament Dismisses Privacy Shield Draft Image

European Data Protection Supervisor Suggests Path After Parliament Dismisses Privacy Shield Draft

Ricci Dipshan

On May 26, coming less than two months after the Article 29 Working Party rebuke of the Privacy Shield, the EU parliament voted 501 to 119 on a resolution calling for negotiations on the agreement to continue. Its criticisms of the text echoed that of the Working Party, namely the Privacy Shield's insufficiency in dealing with U.S. mass surveillance, protecting EU individual data rights and protections, and effectively enforcing its regulations.

Features

Lender Beware: Ignore Suspicious Activity at Your Own Peril Image

Lender Beware: Ignore Suspicious Activity at Your Own Peril

David Kupetz

Recently, the Seventh Circuit held that a lender who should have discovered that its borrower lacked authority to pledge assets is not protected by a good-faith defense to a fraudulent transfer action. Without this defense, the lender lost its security. Should the priority of the lender's claim should be further reduced through equitable subordination?

Wow Your Clients! Image

Wow Your Clients!

Bruce D. Heintz

The old-school term is Client Satisfaction. It's been replaced with Client Delight, which is defined as beyond satisfaction. But, just how good do you have to be, anyway?

Features

Law Firm Retreats Image

Law Firm Retreats

Sharon Meit Abrahams

In today's economy retreats may still be happening, but many have been tailored down and changed to business meeting formats rather than just R & R. To get the most out of the time and expense investment, proper planning is key.

Features

More Small Firm Leaders Embrace Succession Planning Image

More Small Firm Leaders Embrace Succession Planning

Lizzy McLellan

As partners and firm leaders from the baby boomer generation have begun to reach retirement age, legal consultants say succession planning has become a subject of increasing concern at small law firms, and is a topic they encourage those firms to prioritize.

Features

Leasing in Latin America Image

Leasing in Latin America

Emiliano Baidenbaum

Despite the cultural differences and political uncertainties that some investors face, Latin America is an attractive forum for foreign investment and is home to some of the largest economies in the world (Brazil and Mexico). Its proximity to the U.S. and its consumer demand make Latin America a profitable place for business.

Features

<b><i>Crawford v. LVNV Funding, LLC</i></b> Image

<b><i>Crawford v. LVNV Funding, LLC</i></b>

Wayne Kitchens & Sabrina A. Neff

Filing a proof of claim against a bankruptcy estate for a debt the creditor knows is legally unenforceable pursuant to the statute of limitations is unfair, unconscionable, deceptive, or misleading to a consumer under the Federal Debt Collection Practices Act, the Eleventh Circuit recently held in <I>Crawford v. LVNV Funding, LLC.</I>

Court of Appeals Clarifies Condominium Lien Priority Image

Court of Appeals Clarifies Condominium Lien Priority

Stewart E. Sterk

When a first mortgagee also extends a second mortgage loan, and consolidates the two mortgages, does the condominium's lien enjoy priority over the second mortgage? In a recent case, the Court of Appeals held that when both mortgages loans were extended before any default on common charges, both mortgages enjoy priority over the condominium's lien.

Features

The FDA's New Guidance on Data Integrity Image

The FDA's New Guidance on Data Integrity

Alan G. Minsk

The FDA recently released a draft guidance for industry, "Data Integrity and Compliance with CGMP" (Current Good Manufacturing Practices). This article highlights some of the key points in the guidance and attempts to identify the agency's central concerns and recommendations.

Columns & Departments

Drug & Device News Image

Drug & Device News

The latest news that affects the pharmaceutical industry.

Need Help?

  1. Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
  2. Need other assistance? email Customer Service or call 1-877-256-2472.

MOST POPULAR STORIES